JHJennifer F. Hu

Jennifer F. Hu

*This is an algorithmically generated author record based on publicly available information.

Jennifer F. Hu has a total of 126 co-authors. Here are the top co-authors by number of shared publications:

  • Agnieszka Prytuła

    Department of Pediatric Nephrology and Rheumatology, ERKNet Center, Ghent University Hospital, Ghent, Belgium

    1 shared publication
  • Akshata Ijantkar

    Bristol Myers Squibb, Cell Therapy Prod & Analyt Dev, Seattle, WA USA

    1 shared publication
  • Amber Begtrup

    GeneDx, Gaithersburg, Maryland, USA

    1 shared publication
  • Amira Masri

    Department of Pediatrics, Division of Child Neurology, Faculty of Medicine, University of Jordan, Amman, Jordan

    1 shared publication
  • Ankana Daga

    Department of Medicine, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, USA

    1 shared publication
  • Annapurna Poduri

    Epilepsy Genetics Program and F.M. Kirby Neurobiology Center, Department of Neurology, Boston Children's Hospital, Boston, Massachusetts, USA

    1 shared publication

Latest Publications

  • Immunogenicity Risk Assessment of Process-Related Impurities in An Engineered T Cell Receptor Cellular Product

    by Johanna Mora, Daron Forman, Jennifer Hu, Akshata Ijantkar, Jochem Gokemeijer, Kyle L. Kolaja, Caryn Picarillo, Vibha Jawa, Hai Yue, Juliette Lamy, et al.


  • Quantitative mapping of the cellular small RNA landscape with AQRNA-seq

    by Jennifer F. Hu, Daniel Yim, Duanduan Ma, Sabrina M. Huber, Nick Davis, Jo Marie Bacusmo, Sidney Vermeulen, Jieliang Zhou, Thomas J. Begley, Michael S. DeMott, et al.

    Current next-generation RNA-sequencing (RNA-seq) methods do not provide accurate quantification of small RNAs within a sample, due to sequence-dependent biases in capture, ligation and amplification during library preparation. We present a method, absolute quantification RNA-sequencing (AQRNA-seq), that minimizes biases and provides a direct, linear correlation between sequencing read count and copy number for all small RNAs in a sample. Library preparation and data processing were optimized and validated using a 963-member microRNA reference library, oligonucleotide standards of varying length, and RNA blots. Application of AQRNA-seq to a panel of human cancer cells revealed >800 detectable miRNAs that varied during cancer progression, while application to bacterial transfer RNA pools, with the challenges of secondary structure and abundant modifications, revealed 80-fold variation in tRNA isoacceptor levels, stress-induced site-specific tRNA fragmentation, quantitative modification maps, and evidence for stress-induced, tRNA-driven, codon-biased translation. AQRNA-seq thus provides a versatile means to quantitatively map the small RNA landscape in cells.


  • Mutations in KEOPS-complex genes cause nephrotic syndrome with primary microcephaly

    by Daniela A Braun, Jia Rao, Geraldine Mollet, David Schapiro, Marie-Claire Daugeron, Weizhen Tan, Olivier Gribouval, Olivia Boyer, Patrick Revy, Tilman Jobst-Schwan, et al.

    Martin Zenker, Corinne Antignac, Friedhelm Hildebrandt and colleagues report that mutations in OSGEP, TP53RK, TPRKB and LAGE3, genes encoding KEOPS-complex subunits, cause Galloway–Mowat syndrome, a recessive disease characterized by early-onset steroid-resistant nephrotic syndrome and microcephaly. Functional studies suggest that the phenotypes result from impaired protein translation, thus leading to endoplasmic reticulum stress and apoptosis. Galloway–Mowat syndrome (GAMOS) is an autosomal-recessive disease characterized by the combination of early-onset nephrotic syndrome (SRNS) and microcephaly with brain anomalies. Here we identified recessive mutations in OSGEP, TP53RK, TPRKB, and LAGE3, genes encoding the four subunits of the KEOPS complex, in 37 individuals from 32 families with GAMOS. CRISPR–Cas9 knockout in zebrafish and mice recapitulated the human phenotype of primary microcephaly and resulted in early lethality. Knockdown of OSGEP, TP53RK, or TPRKB inhibited cell proliferation, which human mutations did not rescue. Furthermore, knockdown of these genes impaired protein translation, caused endoplasmic reticulum stress, activated DNA-damage-response signaling, and ultimately induced apoptosis. Knockdown of OSGEP or TP53RK induced defects in the actin cytoskeleton and decreased the migration rate of human podocytes, an established intermediate phenotype of SRNS. We thus identified four new monogenic causes of GAMOS, describe a link between KEOPS function and human disease, and delineate potential pathogenic mechanisms.